Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares.
Eisai Stock Down 2.1%
The firm has a market capitalization of $17.64 billion, a PE ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. The company has a quick ratio of 1.77, a current ratio of 2.20 and a debt-to-equity ratio of 0.10. The business has a 50-day moving average price of $61.51 and a 200-day moving average price of $61.51.
Eisai Company Profile
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Read More
- Five stocks we like better than Eisai
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
